Zoetis | ZTS - Betriebsaufwand





Betriebsaufwand Veränderung Datum
AbbVie USD 10.27B 538M 2026-03
Align Technology USD 862.03M 39.18M 2026-03
Bayer EUR 9.88B 452M 2026-03
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Charles River Laboratories USD 875.93M 42.48M 2026-03
Coherus Biosciences USD 51.83M 2.48M 2025-12
Dentsply International USD 1.32B 895M 2026-03
Eli Lilly USD 10.02B 285M 2026-03
Henry Schein USD 3.17B 77M 2026-03
Idexx Laboratories USD 778.23M 3.26M 2026-03
Illumina USD 852M 51M 2026-03
IQVIA Holdings USD 6.22B 4.53B 2026-03
J&J USD 17.44B 1.53B 2026-03
Laboratory Of America USD 3.13B 6.3M 2026-03
Merck USD 18.17B 8.01B 2026-03
Neogen USD 214.5M 15.57M 2025-12
Pacira USD 172.75M 20.93M 2026-03
Perrigo USD 935.6M 89.6M 2026-03
Pfizer USD 90.1B 77.19B 2026-03
Phibro Animal Health USD 361.83M 29.47M 2026-03
Quest Diagnostics USD 2.5B 76M 2026-03
Sanofi EUR 9.31B 1.2B 2026-03
Sanofi EUR 8.98B 1.73B 2026-03
Zoetis USD 3.23B 1.68B 2026-03